Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

Cited by (1,001)

Items 701–800 of 1,001

1. Mucosal T‐cell responses to HIV: responding at the front lines
   Barbara L. Shacklett, J. William Critchfield, April L. Ferre, T. L. Hayes · 2008 · Journal of Internal Medicine
2. Immune checkpoint inhibitors as potential therapy for reverting T-cell exhaustion and reverting HIV latency in people living with HIV
   Jose Miguel Benito, Clara Restrepo, Jesús García‐Foncillas, Norma Ibón Rallón · 2023 · Frontiers in Immunology
3. Disruption of the γc cytokine network in T cells during HIV infection
   Danylo Sirskyj, Jacques Thèze, Ashok Kumar, Marko Kryworuchko · 2008 · Cytokine
4. T Cell and APC Dynamics In Situ Control the Outcome of Vaccination
   Kamal Mohan Khanna, David A. Blair, Anthony T. Vella, Stephen J. McSorley, Sandip K. Datta, Leo Lefrançois · 2010 · The Journal of Immunology
5. Exhaustion and Inflation at Antipodes of T Cell Responses to Chronic Virus Infection
   Luka Čičin‐Šain, Ramon Arens · 2017 · Trends in Microbiology
6. Immune Protection of SIV Challenge by PD-1 Blockade During Vaccination in Rhesus Monkeys
   Enxiang Pan, Fengling Feng, Pingchao Li, Qing Yang, Xiuchang Ma, Chunxiu Wu, Jin Zhao, Hongbin Yan, Rulei Chen, Ling Chen et al. · 2018 · Frontiers in Immunology
7. Longitudinal characterization of phenotypic profile of T cells in chronic hepatitis B identifies immune markers associated with HBsAg loss
   Shue Xiong, Dan Yan Zhu, Boyun Liang, Mingyue Li, Wen Pan, Junyi He, Hua Wang, Kathrin Sutter, Ulf Dittmer, Mengji Lu et al. · 2021 · EBioMedicine
8. The Clonal Expansion Dynamics of the HIV-1 Reservoir: Mechanisms of Integration Site-Dependent Proliferation and HIV-1 Persistence
   Yang-Hui Jimmy Yeh, Kerui Yang, Anya Razmi, Ya‐Chi Ho · 2021 · Viruses
9. Expression of PD-L1, a marker of disease status, is not reduced by HAART in aviraemic patients
   Guglielmo Rosignoli, Alison Cranage, Catherine Burton, Mark Richard Nelson, Alan Steel, Brian Gazzard, Frances M. Gotch, Nesrina Imami · 2007 · AIDS
10. Peripheral tolerance in CD8+ T cells
    Mathangi Srinivasan, Kenneth A. Frauwirth · 2009 · Cytokine
11. T cell sensitivity and the outcome of viral infection
    Lucy Jane Walker, Andrew Kelvin Sewell, Paul Klenerman · 2009 · Clinical & Experimental Immunology
12. Protective effect of a marine oligopeptide preparation from Chum Salmon (Oncorhynchus keta) on radiation‐induced immune suppression in mice
    Ruiyue Yang, Xinrong Pei, Junbo Wang, Zhaofeng Zhang, Haifeng Zhao, Qiong Li, Ming Zhao, Yong Li · 2010 · Journal of the Science of Food and Agriculture
13. CD160 isoforms and regulation of CD4 and CD8 T-cell responses
    Mohamed El Far, Charles Pellerin, Louise Pilote, Jean-Francois Fortin, Ivan A.D. Lessard, Yoav Peretz, Elizabeth Wardrop, Patrick Salois, Richard C. Bethell, Michael G. Cordingley et al. · 2014 · Journal of Translational Medicine
14. PD-1 Expression and Cytokine Secretion Profiles of Mycobacterium tuberculosis-Specific CD4+ T-Cell Subsets; Potential Correlates of Containment in HIV-TB Co-Infection
    Katrina M. Pollock, Damien Montamat‐Sicotte, Lisa Grass, Graham Cooke, Moses Silungwe Kapembwa, Onn Min Kon, Robert D. Sampson, Graham Philip Taylor, Ajit Lalvani · 2016 · PLoS ONE
15. Human Immunodeficiency Virus Type-1 Myeloid Derived Suppressor Cells Inhibit Cytomegalovirus Inflammation through Interleukin-27 and B7-H4
    Ankita Garg, Rodney N. Trout, Stephen A. Spector · 2017 · Scientific Reports
16. Dichotomous Roles of Programmed Cell Death 1 on HIV-Specific CXCR5+ and CXCR5− CD8+ T Cells during Chronic HIV Infection
    Yan‐Mei Jiao, Hong-Ge Yang, Hui-Huang Huang, Bo Tu, Shao-Jun Xing, Lin Mao, Wei Xia, Ran He, Ji-Yuan Zhang, Ruo-Nan Xu et al. · 2017 · Frontiers in Immunology
17. Soluble plasma programmed death 1 (PD-1) and Tim-3 in primary HIV infection
    Eva Zilber, Genevieve Elizabeth Martin, Christian B. Willberg, Julie Fox, Nneka C. Nwokolo, Sarah J. Fidler, John Frater · 2019 · AIDS
18. Novel strategies to eliminate persistent viral infections
    Marianne M. A. Martinic, Matthias G. von Herrath · 2008 · Trends in Immunology
19. Dual blockade of IL-10 and PD-1 leads to control of SIV viral rebound following analytical treatment interruption
    Susan Pereira Ribeiro, Zachary Strongin, Hugo Soudeyns, Felipe ten-Caten, Khader Ghneim, Gabriela Pacheco Sánchez, Giuliana Xavier de Medeiros, Perla M. Del Río Estrada, Adam‐Nicolas Pelletier, Timothy N. Hoang et al. · 2024 · Nature Immunology
20. SAMHD1 Degradation Enhances Active Suppression of Dendritic Cell Maturation by HIV-1
    Nina Hertoghs, Angelic M.G. van der Aar, Laurentia C. Setiawan, Neeltje A. Kootstra, Sonja I. Gringhuis, Teunis B. H. Geijtenbeek · 2015 · The Journal of Immunology
21. Combination Antiretroviral Therapy With Raltegravir Leads to Rapid Immunologic Reconstitution in Treatment-Naive Patients With Chronic HIV Infection
    Suresh Pallikkuth, Margaret A. Fischl, Savita G. Pahwa · 2013 · The Journal of Infectious Diseases
22. Programed death-1/programed death-ligand 1 expression in lymph nodes of HIV infected patients
    Amanda L. Gill, Samantha A. Green, Shahed Azzam Ahmed Abdullah, Cécile Le Saout, Stefania Pittaluga, Hui Chen, Refika Turnier, Jeffrey D. Lifson, Steven Godin, Jing Qin et al. · 2016 · AIDS
23. Immune Checkpoint Blockade in Breast Cancer Therapy
    Xia Bu, Yihui Yao, Xiaoyü Li · 2017 · Advances in experimental medicine and biology
24. CD72/CD100 and PD-1/PD-L1 markers are increased on T and B cells in HIV-1+ viremic individuals, and CD72/CD100 axis is correlated with T-cell exhaustion
    Rafael Correa‐Rocha, Jacobo López‐Abente, Carolina Gutiérrez, Verónica Astrid Pérez-Fernández, Adrián Prieto-Sánchez, Santiago Moreno, María Ángeles Muñoz‐Fernández, Marjorie Pion · 2018 · PLoS ONE
25. Biological Aging and Immune Senescence in Children with Perinatally Acquired HIV
    Annalisa Dalzini, Maria Raffaella Petrara, Giovanni Ballin, Marisa Zanchetta, Carlo Giaquinto, Anita De Rossi · 2020 · Journal of Immunology Research
26. Reversal of T Cell Exhaustion in Chronic HCV Infection
    Sylwia Osuch, Karin Jutta Metzner, Kamila Caraballo Cortés · 2020 · Viruses
27. Combination Immune Checkpoint Blockade Enhances IL-2 and CD107a Production from HIV-Specific T Cells Ex Vivo in People Living with HIV on Antiretroviral Therapy
    Chris Y. H. Chiu, J. Judy Chang, Ashanti Dantanarayana, Ajantha E. Solomon, Vanessa A. Evans, Rachel D. Pascoe, Céline Gubser, Lydie Trautmann, Rémi Fromentin, Nicolas Chomont et al. · 2021 · The Journal of Immunology
28. Beyond adjuvants: Immunomodulation strategies to enhance T cell immunity
    Alice Oliffson Kamphorst, Koichi Araki, Rafi Ahmed · 2015 · Vaccine
29. Programmed Death-1 Expression on Epstein Barr Virus Specific CD8+ T Cells Varies by Stage of Infection, Epitope Specificity, and T-Cell Receptor Usage
    Thomas C. Greenough, Shalyn C. Campellone, Robin Brody, Surbhi Jain, Víctor Sánchez-Merino, Mohan Somasundaran, Katherine Luzuriaga · 2010 · PLoS ONE
30. PD-1 Analysis on CD28−CD27− CD4 T Cells Allows Stimulation-Independent Assessment of CMV Viremic Episodes in Transplant Recipients
    Jan Dirks, Hazal TAŞ, Tina Schmidt, Susanne H. Kirsch, Barbara Christine Gärtner, Urban Sester, Martina Sester · 2013 · American Journal of Transplantation
31. HIV-Infected Children Have Elevated Levels of PD-1+ Memory CD4 T Cells With Low Proliferative Capacity and High Inflammatory Cytokine Effector Functions
    Julia Foldi, Lina Kozhaya, Bret McCarty, Mussa Mwamzuka, Fatma Marshed, Tiina Ilmet, Max Kilberg, Adam Kravietz, Aabid Abdulmajid Ahmed, William Borkowsky et al. · 2017 · The Journal of Infectious Diseases
32. Human Immunodeficiency Virus Infection Promotes Human Papillomavirus-Mediated Anal Squamous Carcinogenesis: An Immunologic and Pathobiologic Review
    Omar Bushara, Katrina Krogh, Samuel Edward Weinberg, Brian Steven Finkelman, Leyu Sun, Jie Liao, Guang‐Yu Yang · 2021 · Pathobiology
33. Anergy in Memory CD4+ T Cells Is Induced by B Cells,
    Sarat Kumar Dalai, Saied Mirshahidi, Alexandre Morrot, Fidel P. Zavala, Scheherazade Sadegh‐Nasseri · 2008 · The Journal of Immunology
34. Expansion of Dysfunctional Tim-3–Expressing Effector Memory CD8+ T Cells during Simian Immunodeficiency Virus Infection in Rhesus Macaques
    Tsuyoshi Fujita, Benjamin J. Burwitz, Glen M. Chew, Jason S. Reed, Reesab Pathak, Elizabeth Seger, Kiera Clayton, James M. Rini, Mario Ostrowski, Naoto Ishii et al. · 2014 · The Journal of Immunology
35. TLR-9 signaling and TCR stimulation co-regulate CD8+ T cell-associated PD-1 expression
    Raymond M.H. Wong, Kent A. Smith, Victor L. Tam, Robb R. Pagarigan, Brenna L. Meisenburg, Angeline M. Quach, Mayra A. Carrillo, Zhiyong Qiu, Adrian I Bot · 2009 · Immunology Letters
36. Type I IFN – A blunt spear in fighting HIV-1 infection
    Chiara Acchioni, Giulia Marsili, Edvige Perrotti, Anna Lisa Remoli, Marco Sgarbanti, Angela Battistini · 2014 · Cytokine & Growth Factor Reviews
37. Structure and function of programmed death (PD) molecules
    A. Folkl, Dorothee Bienzle · 2009 · Veterinary Immunology and Immunopathology
38. Impact of highly active antiretroviral therapy initiation on CD4+ T-cell repopulation in duodenal and rectal mucosa
    Timothy L. Hayes, David M. Asmuth, J. William Critchfield, Thomas H. Knight, Bridget E. McLaughlin, Tammy Yotter, Delandy H. McConnell, Juan Carlos Garcia, Richard B. Pollard, Barbara L. Shacklett · 2012 · AIDS
39. Human Immunodeficiency Virus Type-1 Elite Controllers Maintain Low Co-Expression of Inhibitory Receptors on CD4+ T Cells
    Kajsa Noyan, Son Nguyen, Michael R. Betts, Anders B. Sönnerborg, Marcus Buggert · 2018 · Frontiers in Immunology
40. Development of CAR-T cells for long-term eradication and surveillance of HIV-1 reservoir
    Bingfeng Liu, Wanying Zhang, Hui Zhang · 2019 · Current Opinion in Virology
41. The road to recovery: translating PD-1 biology into clinical benefit
    James L. Riley, Carl H. June · 2006 · Trends in Immunology
42. Early Skewed Distribution of Total and HIV-Specific CD8+ T-Cell Memory Phenotypes during Primary HIV Infection Is Related to Reduced Antiviral Activity and Faster Disease Progression
    Yanina Ghiglione, Juliana Falivene, María Julia Ruiz, Natalia Laufer, Maria Eugenia Socias, Pedro Enrique Cahn, Luis David Giavedoni, Omar Gustavo Sued, María Magdalena Gherardi, Horacio Salomón et al. · 2014 · PLoS ONE
43. HIV-1 Tat affects the programming and functionality of human CD8+ T cells by modulating the expression of T-box transcription factors
    Fabio Sforza, Francesco Nicoli, Eleonora Gallerani, Valentina Finessi, Eva Reali, Aurelio Cafaro, Antonella Caputo, Barbara Ensoli, Riccardo Gavioli · 2014 · AIDS
44. Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus Reservoir
    James L. Riley, Luis J. Montaner · 2017 · The Journal of Infectious Diseases
45. Peering into the HIV reservoir
    Marcial García, Maria José Buzón, Jose Miguel Benito, Norma Ibón Rallón · 2018 · Reviews in Medical Virology
46. PD-1 Expression on NK Cells in Malaria-Exposed Individuals Is Associated with Diminished Natural Cytotoxicity and Enhanced Antibody-Dependent Cellular Cytotoxicity
    Jacqueline Moebius, Rajan Guha, Mary Peterson, Kaveh Abdi, Jeff Skinner, Shanping Li, Gunjan Arora, Boubacar Traoré, Sumati Rajagopalan, Eric O. Long et al. · 2020 · Infection and Immunity
47. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics
    Vinayaka Kotraiah, Timothy W. Phares, Cecille D. Browne, James Pannucci, Marc Mansour, Amy R. Noe, Kenneth D. Tucker, Jayne M. Christen, Charles Reed, Alecia MacKay et al. · 2020 · Frontiers in Immunology
48. Fungal Infections Potentiated by Biologics
    Matthew R Davis, George R. Thompson, Thomas F. Patterson · 2020 · Infectious Disease Clinics of North America
49. HIV Reservoir Decay and CD4 Recovery Associated With High CD8 Counts in Immune Restored Patients on Long-Term ART
    Luxue Zhang, Yan‐Mei Jiao, Chao Zhang, Jin‐Wen Song, Xing Fan, Ruonan Xu, Hui-Huang Huang, Jiyuan Zhang, Lifeng Wang, Chun‐Bao Zhou et al. · 2020 · Frontiers in Immunology
50. Depletion and activation of mucosal CD4 T cells in HIV infected women with HPV-associated lesions of the cervix uteri
    Wilbert Mbuya, Ruby Doryn Mcharo, Jacklina Mhizde, Jonathan Mnkai, Anifrid Mahenge, Maria Mwakatima, Wolfram Mwalongo, Nhamo Chiwerengo, Michael Höelscher, Tessa Lennemann et al. · 2020 · PLoS ONE
51. Epigenetic Features of HIV-Induced T-Cell Exhaustion Persist Despite Early Antiretroviral Therapy
    Genevieve Elizabeth Martin, Debattama R. Sen, Matthew J. Pace, Nicola Robinson, Jodi Meyerowitz, Emily Adland, John Patrick Thornhill, Mathew Jones, Ane Ogbe, Lucia Parolini et al. · 2021 · Frontiers in Immunology
52. Reversal of the CD8+ T-Cell Exhaustion Induced by Chronic HIV-1 Infection Through Combined Blockade of the Adenosine and PD-1 Pathways
    Jing Li, Hui-Huang Huang, Bo Tu, Ming‐Ju Zhou, Wei Hu, Yulong Fu, Xiaoyu Li, Tao Yang, Jin‐Wen Song, Xing Fan et al. · 2021 · Frontiers in Immunology
53. Assessment of nivolumab in HIV-Infected patients with advanced non-small cell lung cancer after prior chemotherapy. The IFCT-1602 CHIVA2 phase 2 clinical trial
    A. Lavolé, Julien Mazières, Sophie Schneider, Solenn Brosseau, Lize Kiakouama, Laurent Greillier, Amélie Guihot, Baptiste Abbar, Marine Baron, Alain Makinson et al. · 2021 · Lung Cancer
54. CD8+ T-cell responses in HIV controllers: potential implications for novel HIV remission strategies
    Rachel Lena Rutishauser, Lydie Trautmann · 2022 · Current Opinion in HIV and AIDS
55. The role of viruses in HIV-associated lymphomas
    Kathryn Anne Lurain, Ramya Ramaswami, Robert Yarchoan · 2022 · Seminars in Hematology
56. Soluble immune checkpoints as correlates for HIV persistence and T cell function in people with HIV on antiretroviral therapy
    Chris Y. H. Chiu, Maya Dyveke Schou, James H. McMahon, Steven G. Deeks, Rémi Fromentin, Nicolas Chomont, Michelle Wykes, Thomas A. Rasmussen, Sharon R. Lewin · 2023 · Frontiers in Immunology
57. Foxo3a: An integrator of immune dysfunction during HIV infection
    Julien van Grevenynghe, Rafael A. Cubas, Sandrina DaFonseca, Talibah U. Metcalf, Cecile L. Tremblay, Lydie Trautmann, Rafick‐Pierre Sékaly, John D. Schatzle, Elias K. Haddad · 2012 · Cytokine & Growth Factor Reviews
58. A suspenseful game of 'hide and seek' between virus and host
    Michael B. A. Oldstone · 2007 · Nature Immunology
59. Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes
    Liguo Niu, James M. Termini, Saravana kumar Kanagavelu, Sachin Gupta, Morgane Rolland, Viraj Kulkarni, George N. Pavlakis, Barbara K. Felber, James I. Mullins, Margaret A. Fischl et al. · 2011 · Vaccine
60. Programmed death-1 expression is associated with the disease status in hepatitis B virus infection
    Pian Ye, Zhihong Weng, Shuling Zhang, Jian-Ao Zhang, Lei Zhao, Ji-Hua Dong, Shenghua Jie, Ran Pang, Rong-Hua Wei · 2008 · World Journal of Gastroenterology
61. Dysfunctional phenotypes of CD4+ and CD8+ T cells are comparable in patients initiating ART during early or chronic HIV-1 infection
    Sylvie Amu, Rebecka Lantto, Yonas Bekele, Aikaterini Nasi, Carina Bengtsson, Bence Réthi, Sam Sorial, Genny Meini, Maurizio Zazzi, Bo Hejdeman et al. · 2016 · Medicine
62. Recent Advances in Understanding the Biomolecular Basis of Chronic Beryllium Disease: A Review
    T McCluskey, Virginia Buchner, R. William Field, Brian L. Scott · 2009 · Reviews on Environmental Health
63. Transcriptional Signals of T-cell and Corticosteroid-sensitive Genes Are Associated With Future Acute Cellular Rejection in Cardiac Allografts
    Mandeep R. Mehra, JON A. KOBASHIGAWA, Mario C.-H.K. Deng, Kenneth C. Fang, Tod M. Klingler, Preeti G. Lal, Steven J. Rosenberg, Patricia A. Uber, Randall C. Starling, Srinivas Murali et al. · 2007 · The Journal of Heart and Lung Transplantation
64. Functional Tolerance of CD8+ T Cells Induced by Muscle-Specific Antigen Expression
    Sébastien Calbo, Héloïse M Delagreverie, Christophe Arnoult, François‐Jérôme Authier, François Tron, Olivier Boyer · 2008 · The Journal of Immunology
65. PD-1 Predicts CD4 Loss Rate in Chronic HIV-1 Infection Better Than HIV RNA and CD38 But Not in Cryopreserved Samples
    Dag Kvale, Malin Holm Meyer‐Myklestad, Frank Olav Pettersen · 2008 · Current HIV Research
66. Terminal Effector CD8 T Cells Defined by an IKZF2+IL-7R− Transcriptional Signature Express FcγRIIIA, Expand in HIV Infection, and Mediate Potent HIV-Specific Antibody-Dependent Cellular Cytotoxicity
    Prossy Naluyima, Kerri G. Lal, Margaret C. Costanzo, Gustavo H. Kijak, Veronica D. Gonzalez, Kim G. Blom, Leigh Anne Eller, Matthew Creegan, Ting Hong, Dohoon Kim et al. · 2019 · The Journal of Immunology
67. Suppression of HIV Replication by Antiretroviral Therapy Reduces TIM-3 Expression on HIV-Specific CD8 + T Cells
    Afework Kassu, Roland A. Marcus, Michelle D’Souza, Elizabeth A. Kelly-McKnight, Brent E. Palmer · 2010 · AIDS Research and Human Retroviruses
68. Association Between Hepatitis B Viral Burden in Chronic Infection and a Functional Single Nucleotide Polymorphism of the PDCD1 Gene
    Linghua Zheng, Dongling Li, Fu‐Sheng Wang, Hao Wu, Xiaozhu Li, Junliang Fu, Xinyue Chen, Lizhong Wang, Yang Liu, Shengdian Wang · 2010 · Journal of Clinical Immunology
69. Molecular cloning and expression analysis of bovine programmed death-1
    Ryoyo Ikebuchi, Satoru Konnai, Yuji Sunden, Misao Onuma, Kazuhiko Ohashi · 2010 · Microbiology and Immunology
70. Altered expression of the costimulatory molecules CD80, CD86, CD152, PD-1 and ICOS on T-cells from paracoccidioidomycosis patients: Lack of correlation with T-cell hyporesponsiveness
    Camila R. Cacere, Maria José Soares Mendes‐Giannini, Cor Jésus Fernandes Fontes, Adriana Kono, Alberto J.S. Duarte, Gil Benard · 2008 · Clinical Immunology
71. Immune Response Activation
    Guy Huynh Thien Duc · 2014 · InTech eBooks
72. The Duration of Exposure to HIV Modulates the Breadth and the Magnitude of HIV-Specific Memory CD4+ T Cells
    Souheil‐Antoine Younes, Lydie Trautmann, Bader Yassine‐Diab, Lena H. Kalfayan, Anne‐Elen Kernaleguen, Thomas O. Cameron, R Boulassel, Lawrence J. Stern, Jean‐Pierre Routy, Zvi Grossman et al. · 2007 · The Journal of Immunology
73. The Woodchuck, a Nonprimate Model for Immunopathogenesis and Therapeutic Immunomodulation in Chronic Hepatitis B Virus Infection
    Michael Roggendorf, Anna D. Kosinska, Jia Liu, Mengji Lu · 2015 · Cold Spring Harbor Perspectives in Medicine
74. Cancer Immunotherapy Trials Network 12: Pembrolizumab in HIV-Associated Kaposi Sarcoma
    Kathryn Anne Lurain, Ramya Ramaswami, Irene Ekwede, Vanessa Anne Eulo, Gaurav Goyal, Manoj P. Menon, Thomas Odeny, Elad Sharon, Michael J. Wagner, Chia-ching J. Wang et al. · 2024 · Journal of Clinical Oncology
75. Efficient In Vitro Expansion of Human Immunodeficiency Virus (HIV)-Specific T-Cell Responses bygagmRNA-Electroporated Dendritic Cells from Treated and Untreated HIV Type 1-Infected Individuals
    Ellen R. Van Gulck, Guido L. Vanham, Leo Heyndríckx, Sandra Coppens, Katleen Vereecken, Derek Atkinson, Éric Florence, Ilse Kint, Zwi Nisan Berneman, Viggo F. Van Tendeloo · 2008 · Journal of Virology
76. CD4 T Cells Mediate Both Positive and Negative Regulation of the Immune Response to HIV Infection: Complex Role of T Follicular Helper Cells and Regulatory T Cells in Pathogenesis
    Chansavath Phetsouphanh, Yin Xu, John James Zaunders · 2015 · Frontiers in Immunology
77. KLRG1+NKG2A+ CD8 T Cells Mediate Protection and Participate in Memory Responses during γ-Herpesvirus Infection
    Stephanie S. Cush, Emilio Flaño · 2011 · The Journal of Immunology
78. Impact of Anti PD-1 Immunotherapy on HIV Reservoir and Anti-Viral Immune Responses in People Living with HIV and Cancer
    Marine Baron, Cathia Soulié, A. Lavolé, Lambert Assoumou, Baptiste Abbar, Baptiste Fouquet, Alice Rousseau, Marianne Veyri, Assia Samri, Alain Makinson et al. · 2022 · Cells
79. High-throughput virtual screening of small-molecule inhibitors targeting immune cell checkpoints to discover new immunotherapeutics for human diseases
    Satyendra Singh, Ketan Kumar, Mamta Panda, Aryan Srivastava, Amit Mishra, Vijay Kumar Prajapati · 2022 · Molecular Diversity
80. Transcriptional profiling of feline infectious peritonitis virus infection in CRFK cells and in PBMCs from FIP diagnosed cats
    Mohammad Syamsul Reza Harun, Choong Oi Kuan, Gayathri Thevi Selvarajah, Tan Sheau Wei, Siti Suri Arshad, Mohd Hair Bejo, Abdul Rahman Omar · 2013 · Virology Journal
81. High CD8+ T Cell Activation Marks a Less Differentiated HIV-1 Specific CD8+ T Cell Response that Is Not Altered by Suppression of Viral Replication
    Jason D. Barbour, Lishomwa C. Ndhlovu, Qi Xuan Tan, Terence N. Ho, Lorrie Epling, Barry M. Bredt, Jay A. Levy, Frederick M. Hecht, Elizabeth Sinclair · 2009 · PLoS ONE
82. Feline programmed death and its ligand: Characterization and changes with feline immunodeficiency virus infection
    A. Folkl, Xue Wen, Elizabeth A. Kuczynski, Mary E. Clark, Dorothee Bienzle · 2009 · Veterinary Immunology and Immunopathology
83. Correlations of programmed death 1 expression and serum IL-6 level with exhaustion of cytomegalovirus-specific T cells after allogeneic hematopoietic stem cell transplantation
    Tomonori Kato, Tetsuya Nishida, Yoshinori Ito, Miho Murase, Makoto Murata, Tomoki Naoe · 2014 · Cellular Immunology
84. Contact-Dependent Interference with Invariant NKT Cell Activation by Herpes Simplex Virus-Infected Cells
    Lidija Bosnjak, Peter Sahlström, Dominic Paquin‐Proulx, Edwin Leeansyah, Markus Moll, Johan K. Sandberg · 2012 · The Journal of Immunology
85. Kill
    Lydie Trautmann · 2016 · Current Opinion in HIV and AIDS
86. Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescencein situhybridization (FISH) to select the optimal patients for matched therapy?
    Young Kwang Chae, Ayush Arya, Lauren S. Chiec, Hiral Anil Shah, Ari Joseph Rosenberg, Sandip Pravin Patel, Kirtee Raparia, Jaehyuk Choi, Derek Alan Wainwright, Victoria Meucci Villaflor et al. · 2017 · Oncotarget
87. Enhancement of Antiviral CD8+ T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with Pembrolizumab
    Oscar Blanch-Lombarte, Cristina Gálvez, Boris Revollo, Esther Jiménez‐Moyano, Josep Maria Llibre, José Luís Manzano, Aram Boada, Judith Dalmau, Daniel E. Speiser, Bonaventura Clotet et al. · 2019 · Journal of Clinical Medicine
88. A brief history of HIV vaccine research: stepping back to the drawing board?
    Frank F. Miedema · 2008 · AIDS
89. Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real-world OncoVIHAC ANRS CO24 cohort study
    Lambert Assoumou, Raghiatou Baldé, Christine Katlama, Baptiste Abbar, Pierre Delobel, Thierry Allègre, A. Lavolé, Alain Makinson, Olivia Zaegel‐Faucher, Laurent Greillier et al. · 2024 · Journal for ImmunoTherapy of Cancer
90. GBV‐C coinfection is negatively correlated to Fas expression and Fas‐mediated apoptosis in HIV‐1 infected patients
    Maren Moenkemeyer, Reinhold Ernst Schmidt, Heiner H. Wedemeyer, Hans Ludger Tillmann, Hans Heiken · 2008 · Journal of Medical Virology
91. Circulating Th1, Th2, Th17, Treg, and PD-1 Levels in Patients with Brucellosis
    Rongjiong Zheng, Songsong Xie, Qiong Zhang, Ling Cao, Shaniya Niyazi, Xiaobo Lu, Lihua Sun, Yan Zhou, Yuexin Zhang, Kai Wang · 2019 · Journal of Immunology Research
92. Mechanisms of alloimmunization in sickle cell disease
    Krystalyn E. Hudson, Ross M. Fasano, Matthew S. Karafin, Jeanne E. Hendrickson, Richard O. Francis · 2019 · Current Opinion in Hematology
93. Nonsmall cell lung cancer from HIV-infected patients expressed programmed cell death-ligand 1 with marked inflammatory infiltrates
    Charlotte Domblides, Martine Antoine, Cécile Hamard, Nathalie Rabbe, Anita Rodenas, Thibault Vieira, Perrine Créquit, Jacques L. Cadranel, A. Lavolé, Marie Wislez · 2017 · AIDS
94. Elevated expression of miR-146a correlates with high levels of immune cell exhaustion markers and suppresses cellular immune function in chronic HIV-1-infected patients
    Ting Yu, Zhao Ju, Mingqi Luo, Rong‐Hua Hu, Yan Teng, Linlin Xie, Chaojie Zhong, Lang Chen, Wei Hou, Yong Xiong et al. · 2019 · Scientific Reports
95. HIV-1-Specific CAR-T Cells With Cell-Intrinsic PD-1 Checkpoint Blockade Enhance Anti-HIV Efficacy in vivo
    Zhengtao Jiang, Huitong Liang, Hanyu Pan, Liang Yue, Hua Wang, Xinyi Yang, Panpan Lu, Xiao Zhang, Jinlong Yang, Dengji Zhang et al. · 2021 · Frontiers in Microbiology
96. The HIV Latency Reversal Agent HODHBt Enhances NK Cell Effector and Memory-Like Functions by Increasing Interleukin-15-Mediated STAT Activation
    Amanda B. Macedo, Callie Levinger, Bryan Nguyen, Jonathan Richard, Mamta Gupta, Carolina Colli Cruz, Andrés Finzi, Katherine Bakshian Chiappinelli, Keith A. Crandall, Alberto Bosque · 2022 · Journal of Virology
97. siRNA Knockdown of PD-L1 and PD-L2 in Monocyte-Derived Dendritic Cells only Modestly Improves Proliferative Responses to Gag by CD8+ T Cells from HIV-1-Infected Individuals
    Gaëlle Breton, Bader Yassine‐Diab, Lillian B. Cohn, Mohamed Rachid Boulassel, Jean‐Pierre Routy, Rafick‐Pierre Sékaly, Ralph M. Steinman · 2009 · Journal of Clinical Immunology
98. Study of CD4+CD8+ Double positive T‐lymphocyte phenotype and function in Indian patients infected with HIV‐1
    Neeraj K. Chauhan, Madhu Vajpayee, Kamalika Mojumdar, Ravinder Singh, Alpana Singh · 2012 · Journal of Medical Virology
99. Imbalanced Production of Cytokines by T Cells Associates with the Activation/Exhaustion Status of Memory T Cells in Chronic HIV Type 1 Infection
    Kaori Nakayama, Hitomi Nakamura, Michiko Koga, Tomohiko Koibuchi, Takeshi Fujii, Toshiyuki Miura, Aikichi Iwamoto, Ai Kawana‐Tachikawa · 2011 · AIDS Research and Human Retroviruses
100. Hepatitis C virus infection: A “liaison a trois” amongst the virus, the host, and chronic low-level inflammation for human survival
     Vincenzo Barnaba · 2010 · Journal of Hepatology